MINAPHARM Pharmaceuticals

E£776.93As of Sun 8 Nov 2026, 12:00 UTC
EGX:MIPHHealthcare
Country Egypt
PE (Fwd) •••
TSR 10Y CAGR 34.03%
Div yield 0.32%
ROE 6.64%
Pharmaceutical Preparations
Beta (5Y) 0.36
PE TTM 26.54
TSR TTM 144.02%
Mkt cap E£9.153B
ROIC 9.43%
SE Grade™
Value
Quality
Moat
Consensus
Reference
E£802
3.25%
113.25%
Hold 5|4|10|5|10
4Q25
1Q26
2Q26
3Q26
Earnings per shareE£
10.58
10.15
10.88
10.35
7.86%
4.51%
12.42%
(2.96%)
RevenueE£M
660.3
662.9
653.3
634.3
16.10%
10.91%
6.66%
(1.72%)
Peers (US$173.5M)
Cap (US$)
PE
Capital
TTM
5Y
10Y
Leveragex
0.951
0.031
0.028
EBIT/Intx
6.737
0.708
0.679
Own earn%
(148.00)
(28.12)
(27.96)
Sh yield%
38.04
9.56
9.28
Owners
Insiders/Inst%
6.69
57.83
Short interest%
1.11
SBC / revenue%
0.45
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
7
Op margin range%
0–4
$1 testx
—
Incr. ROIC%
18